The article considers the possibility of producing isotopes at nuclear power plants with RBMK-1000 reactors. In particular, the specialists of NIKIET developed technical documentation for substantiating the production and expanding the range of medical isotopes at the Phase 2 power units of the Leningrad NPP. The combination of design works and calculation justification demonstrated the possibility of the safe conversion and operation of two standard channels in the RBMK-1000 control and protection system of the Leningrad NPP power units 3 and 4 for irradiating starting substances with thermal neutrons and producing 131I, 153Sm, and 177Lu. By expanding the production of medical isotopes at the Leningrad NPP, as well as at other RBMK-1000 nuclear power plants in the future, current radioisotope demand from the pharmaceutical industry can be met at the same time as enlarging the number of available preparations.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Atomnaya Énergiya, Vol. 133, No. 5–6, pp. 288–292, November–December, 2022.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Alimov, Y.V., Biryukov, A.N., Mamontov, A.Y. et al. Conversion of CPS Channels at the Leningrad NPP Power Units 3 and 4 for the Production of Radionuclides. At Energy 133, 307–311 (2023). https://doi.org/10.1007/s10512-023-01013-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10512-023-01013-3